| Financial Year |
March 31 2023 |
| Monetary Funds |
742,785,297.13 |
| Held-for-trading Financial Assets |
45,590,160.29 |
| Notes Receivable |
78,104,797.40 |
| Accounts Receivable |
558,435,128.42 |
| Advances to Suppliers |
144,515,606.66 |
| Other Receivables |
74,089,701.60 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,079,554,026.52 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
291,319,878.02 |
| Total Current Assets |
3,143,347,173.45 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
29,301,130.53 |
| Investment Properties |
-- |
| Fixed Assetes |
1,729,822,880.23 |
| Under-construction Projects |
73,085,205.62 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
131,966,055.36 |
| R&D expenses |
-- |
| Goodwill |
88,792,434.48 |
| Long-Term Deferred and Prepaid Expenses |
57,931,547.68 |
| Deferred Income Tax Assets |
54,351,937.48 |
| Other Non-Current Assets |
92,432,740.84 |
| Sub-Total of Non-Current Assets |
2,402,579,474.88 |
| Total Assets |
5,545,926,648.33 |
| Short-Term Loans |
930,990,475.85 |
| Trading Financial liabilities |
6,477,586.15 |
| Notes Payable |
56,920,689.59 |
| Accounts Payable |
543,991,190.74 |
| Accounts Received In Advance |
4,403,784.01 |
| Employee Compensation Payable |
41,751,803.47 |
| Taxes Payable |
19,963,972.36 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
114,652,944.67 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
359,680,506.69 |
| Other Current Liabilities |
55,495,830.91 |
| Sub-Total of Current Liabilities |
2,501,841,351.48 |
| Long-term Loans |
102,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
384,793,917.23 |
| Special Payable |
-- |
| Estimatied Liabilities |
65,704,240.59 |
| Deferred Income Tax Liabilities |
8,742,637.42 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
674,731,328.20 |
| Total Liabilities |
3,176,572,679.68 |
| Paid-In Capital(Or Share Stock) |
142,625,500.00 |
| Capital Surplus |
1,461,907,629.99 |
| Surplus Reserve |
67,017,189.52 |
| LESS:Treasury Stock |
6,172,722.65 |
| Undistributed Profits |
631,110,714.68 |
| Minority Stockholder's Interest |
72,847,862.70 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,296,506,105.95 |
| Owner's Equity（Stockholder's Equity） |
2,369,353,968.65 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
5,545,926,648.33 |
